We are live on
!
Find out more
MP
MSD Partners Portfolio holdings
AUM
$82.3M
1-Year Est. Return
15.13%
This Fund
S&P 500
This Quarter
Est. Return
-17.92%
1 Year Est. Return
-15.13%
3 Year Est. Return
-8.08%
5 Year Est. Return
-28.09%
10 Year Est. Return
+16.55%
AUM
$1.02B
AUM Growth
-$226M
(-18%)
Cap. Flow
+$135K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
99.61%
Holding
19
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Theriva Biologics
TOVX
|
+$209K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
+$74.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 86.1% |
| 2 | Consumer Staples | 6.84% |
| 3 | Consumer Discretionary | 3.11% |
| 4 | Utilities | 1.59% |
| 5 | Energy | 0.68% |
Similar funds
FLC
1C
APW
VPW
KL
BCM
WAG
BC
MSD Partners's Q2 2024 Portfolio in Review
As of Q2 2024, MSD Partners held 19 positions worth $1.02B, down 18% from $1.25B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MSD Partners's Q2 2024 filing shows 1 new and 1 closed positions. Its largest new stake was Theriva Biologics: 23,936 shares worth $141K. The largest sale was Cue Health Inc. Common Stock, an estimated $74.5K.
By sector, the portfolio is most concentrated in Industrials at 86% of assets, down from 88% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- MSD Partners's largest Q2 2024 buy was Theriva Biologics: 23,936 shares worth $141K.
- MSD Partners fully exited Cue Health Inc. Common Stock in Q2 2024, selling an estimated $74.5K.
- MSD Partners's ten largest holdings make up 100% of its $1.02B portfolio in Q2 2024.
- MSD Partners opened 1 new position and closed 1 in Q2 2024.
- MSD Partners's portfolio value fell 18% quarter-over-quarter to $1.02B.
Based on MSD Partners's 13F filing for Q2 2024, filed 14 Aug 2024.